The cancer pathway is also associated with two genes implicated in the cytoskeletal remodeling and network, ANXA2 and TUBA1A, linked to HCC and cell migration (i.e., metastasis development) as shown previously [66,67], thus predicting the fate of the NASH (Figure 8F). This evidence concerns the gene ANXA2 and hepatocellular carcinoma.